Dow Chemical and DuPont are on the verge of offering to sell research and development capability in response to Brussels’ antitrust concerns over the companies’ planned $140bn merger. The case, which will decide on Tuesday whether to approve the deal, has become a test of European competition regulators’ approach to industrial innovation.
The investigation is the first of three agrichemical megadeals, together worth nearly $250bn, that Margrethe Vestager, EU competition commissioner, will examine this year. Dow and DuPont are seeking to stop the merger being blocked, amid concerns from politicians and consumer groups.
Brussels’ objections to the deal have attracted particular scrutiny, because it marks the first time the commission has threatened to block a deal primarily based on concerns that it could cut innovation in a whole market. Previous antitrust cases have cited a narrower range of risks to product development in specific markets.
Full Content: Financial Times
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas